These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30833063)

  • 1. Eliminating hepatitis C.
    Burki T
    Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis on the political agenda.
    Holt E
    Lancet Infect Dis; 2018 Jan; 18(1):30. PubMed ID: 29303738
    [No Abstract]   [Full Text] [Related]  

  • 3. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 4. Eliminating hepatitis from the Eastern Mediterranean Region.
    Fikri M
    East Mediterr Health J; 2017 Aug; 23(7):459-460. PubMed ID: 28853128
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies.
    Wu GH; Pwu RF; Chen SC
    J Formos Med Assoc; 2018 Dec; 117(12):1044-1045. PubMed ID: 30449458
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.
    Naggie S; Wyles D
    J Infect Dis; 2020 Nov; 222(Suppl 9):S741-S744. PubMed ID: 33245351
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis at the United Nations: a missed chance.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2018 Nov; 18(11):1161. PubMed ID: 30507393
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute hepatitis C.
    Heller T; Hoofnagle J; Liang TJ; Rehermann B
    Gastroenterology; 2009 Jun; 136(7):2411. PubMed ID: 19409987
    [No Abstract]   [Full Text] [Related]  

  • 9. Joint efforts urgently needed at times of emerging tuberculosis drug resistance.
    Allerberger F; Cambau E; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):129-130. PubMed ID: 27592088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C: cost of eradication ].
    Nau JY
    Rev Med Suisse; 2014 Jan; 10(415):306-7. PubMed ID: 24624702
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis-a World Health Organization Perspective.
    Sotgiu G; Sulis G; Matteelli A
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination on the agenda for hepatitis C.
    Burki T
    Lancet Infect Dis; 2014 Jun; 14(6):452-3. PubMed ID: 24971446
    [No Abstract]   [Full Text] [Related]  

  • 13. The global elimination of hepatitis C?
    Sonderup MW
    S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in visceral leishmaniasis control and elimination in the developing countries: A review.
    Hailu T; Yimer M; Mulu W; Abera B
    J Vector Borne Dis; 2016; 53(3):193-8. PubMed ID: 27681541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Weiß J
    Z Gastroenterol; 2016 Mar; 54(3):214. PubMed ID: 27500296
    [No Abstract]   [Full Text] [Related]  

  • 16. The phases of hepatitis C elimination: achieving WHO elimination targets.
    Pedrana A; Munari S; Stoové M; Doyle J; Hellard M
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435
    [No Abstract]   [Full Text] [Related]  

  • 17. MEDICINE. Global control of hepatitis C virus.
    Cox AL
    Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940
    [No Abstract]   [Full Text] [Related]  

  • 18. Leaving no one behind: Towards equitable global elimination of hepatitis C.
    Dahl EH; Zahid H; Aslam K; Jafri W
    J Glob Health; 2020 Jun; 10(1):010308. PubMed ID: 32257136
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus elimination: laying the foundation for achieving 2030 targets.
    Dore GJ; Bajis S
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):91-92. PubMed ID: 33257831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
    Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
    Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.